{"product_id":"cjc-1295-sem-dac-10mg","title":"CJC-1295 sem DAC 10mg","description":"\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eCJC-1295 — Advanced Growth Hormone Research Peptide\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGrowth Hormone Signaling | GHRH Receptor Research | IGF-1 Regulation | Endocrine Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eProduct Overview\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCJC-1295 is a synthetic peptide analogue of Growth Hormone-Releasing Hormone (GHRH), developed to investigate the stimulation of endogenous growth hormone (GH) secretion and its downstream effects on insulin-like growth factor 1 (IGF-1).\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCJC-1295 interacts with GHRH receptors in the anterior pituitary gland, stimulating the body's growth hormone signaling system rather than acting as externally administered growth hormone.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe compound has attracted scientific interest in endocrinology, growth hormone regulation, metabolic physiology, and age-related hormonal research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAlthough frequently discussed in connection with muscle development, fat metabolism, physical recovery, and healthy aging, \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ethese potential benefits have not been established through adequate clinical efficacy trials\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eMechanism of Action\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eCJC-1295 acts through the GHRH signaling pathway, which plays an essential role in regulating endogenous growth hormone secretion.\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGHRH Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Stimulates receptors in the anterior pituitary gland involved in growth hormone release.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGrowth Hormone Secretion:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Clinical research has demonstrated increased circulating GH concentrations following exposure to the long-acting form of CJC-1295.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eIGF-1 Regulation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Increased GH signaling can stimulate hepatic and peripheral production of IGF-1, an important mediator of growth hormone activity.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eHormonal Pulsatility:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Research has investigated whether the natural pulsatile pattern of GH secretion is maintained during prolonged GHRH receptor stimulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eEndocrine Signaling:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Provides an experimental model for investigating interactions between pituitary hormone secretion, metabolism, and growth-related biological pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eCJC-1295 Variants: DAC vs. Non-DAC\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eTwo peptide formulations are commonly discussed in the research peptide market, although their scientific nomenclature and clinical evidence differ.\u003c\/span\u003e\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003e\u003cspan\u003eCharacteristic\u003c\/span\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cspan\u003eCJC-1295 with DAC\u003c\/span\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cspan\u003eCJC-1295 without DAC\u003c\/span\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eAlternative Name\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eLong-acting CJC-1295\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eModified GRF (1-29)\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eStructure\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eGHRH analogue incorporating a Drug Affinity Complex\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eShort-acting modified GHRH analogue\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eDuration of Action\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eProlonged\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eShorter\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eAlbumin Binding\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eDesigned for extended binding to circulating albumin\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eDoes not contain the DAC modification\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003eHuman Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eLimited controlled pharmacokinetic and pharmacodynamic studies\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eVery limited direct human clinical evidence\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003cspan\u003ePrimary Research Focus\u003c\/span\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eSustained GH and IGF-1 signaling\u003c\/span\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cspan\u003eShort-duration GHRH receptor signaling\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eScientific Clarification:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e The term “CJC-1295 without DAC” is commonly used commercially for Modified GRF (1-29). These formulations should not be considered interchangeable, and clinical findings from the DAC-containing compound cannot automatically be applied to the non-DAC version.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eClinical Research \u0026amp; Scientific Findings\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eEarly human research involving long-acting CJC-1295 demonstrated measurable changes in growth hormone and IGF-1 concentrations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn a published clinical investigation involving healthy adults:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eMean circulating GH concentrations increased approximately \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e2- to 10-fold\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e after a single administration.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eMean circulating IGF-1 concentrations increased approximately \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e1.5- to 3-fold\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eThe estimated elimination half-life was approximately \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e5.8–8.1 days\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eSustained hormonal effects were observed during the study period.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese findings demonstrate pharmacological activity but do not establish improvements in muscle growth, body composition, exercise recovery, sleep quality, or longevity.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003ePotential Research Applications\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e1. Growth Hormone Regulation\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInvestigation of endogenous GH secretion and the biological mechanisms controlling pituitary hormone release.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e2. IGF-1 Signaling\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExploration of GH-dependent IGF-1 production and its role in cellular growth, tissue regulation, and endocrine physiology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e3. Skeletal Muscle Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExamination of GH\/IGF-1 signaling pathways associated with muscle protein metabolism and tissue adaptation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e4. Adipose Tissue \u0026amp; Metabolic Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInvestigation of interactions between growth hormone signaling, lipid metabolism, and body composition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e5. Recovery \u0026amp; Tissue Physiology\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearch into the biological roles of GH and IGF-1 in tissue turnover and repair mechanisms.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e6. Sleep \u0026amp; Age-Related Endocrine Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExploration of relationships between growth hormone secretion, sleep physiology, and age-related hormonal changes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese are \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eexperimental research areas rather than clinically established benefits of CJC-1295\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eResearch Involving Ipamorelin\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eCJC-1295 is sometimes discussed alongside Ipamorelin, a growth hormone secretagogue that acts through a different receptor system.\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCJC-1295:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Targets the GHRH receptor signaling pathway.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eIpamorelin:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Acts primarily through the growth hormone secretagogue receptor (GHSR-1a).\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThe combination is of experimental interest because the two substances influence distinct pathways associated with GH secretion.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHowever, controlled clinical evidence establishing the safety, efficacy, or therapeutic superiority of this combination is insufficient.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eSafety \u0026amp; Potential Adverse Effects\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCJC-1295 remains an investigational peptide without established approval for routine clinical use in the European Union.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eReported or potential adverse effects include:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eInjection-site reactions\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eFlushing and vasodilatory reactions\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eIncreased heart rate\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eHeadaches or dizziness\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eFluid retention\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003ePossible alterations in glucose regulation and insulin sensitivity\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003ePotential complications associated with increased GH\/IGF-1 signaling\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eLong-term safety, immunogenicity, and possible risks associated with sustained hormonal stimulation remain insufficiently characterized.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe complete safety profile of CJC-1295, particularly for prolonged exposure or combination with other growth hormone secretagogues, has not been established.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eScientific Evidence \u0026amp; Limitations\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eAlthough early human studies have demonstrated increases in GH and IGF-1 concentrations, important limitations remain:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eNo established clinical evidence of meaningful muscle hypertrophy.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eNo conclusive evidence of sustained fat loss.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eNo proven anti-aging or longevity benefits.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eInsufficient evidence supporting improved athletic performance or recovery.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eLimited long-term safety data.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eLack of adequate controlled human studies for commonly marketed non-DAC formulations.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eResearch Use Only\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eFOR SCIENTIFIC AND LABORATORY RESEARCH PURPOSES ONLY.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIntended exclusively for qualified professionals conducting legitimate scientific investigations in endocrinology, peptide pharmacology, and metabolic research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eNot approved for general human or veterinary use. Not intended for personal injection, self-administration, bodybuilding enhancement, or unauthorized therapeutic applications.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNot intended to diagnose, treat, cure, or prevent any disease.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearch-use labeling does not constitute authorization for clinical administration or commercial distribution as an approved medicinal product.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePEPTITAN — PRECISION. SCIENCE. RESEARCH.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":59502075543816,"sku":null,"price":120.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1078\/2942\/8488\/files\/Frasco_de_Vidro_com_Arcos_Dourados.png?v=1794657660","url":"https:\/\/peptgrind.com\/products\/cjc-1295-sem-dac-10mg","provider":"peptitan","version":"1.0","type":"link"}